Drugs / Magnesium Sulfate
last change 10 days ago re-read 8 days ago

Magnesium Sulfate

Other / unclassified

Developed for
preeclampsia · asthma · atrial fibrillation · severe pre-eclampsia · acute asthma · chronic obstructive pulmonary disease · neuropathy, painful · osteoarthritis, knee
+83 more · breast cancer · cerebral palsy · ischemic stroke · myofascial pain syndrome · perinatal asphyxia · delirium · atrial flutter · bronchiolitis · cardiac rhythm disease · childhood onset asthma · intracerebral hemorrhage · magnesium deficiency · obesity disorder · peripheral neuropathy · periventricular leukomalacia · pulmonary hypertension, neonatal · sickle cell disease · stroke disorder · traumatic brain injury · acute kidney injury · Alagille syndrome · appendicitis · arterial disorder · benign prostatic hyperplasia · benign shuddering attacks · biliary atresia · brain hypoxia - ischemia · brain injury · brain ischemia · bronchitis · cancer-related condition · cardiac arrest · carpal tunnel syndrome · chemotherapy-induced neuropathy · chemotherapy-induced toxicity · chronic pain syndrome · chronic rhinosinusitis · cluster headache syndrome · dyskinesia of esophagus · dysmenorrhea · eclampsia · female breast carcinoma · headache disorder · hepatocellular carcinoma · hypertensive disorder · hypospadias · hypotensive disorder · infectious disease with sepsis · ischemic disease · meningioma · metastatic melanoma · migraine disorder · muscle cramps, familial · ocular hypertension · pancreatitis · pelvis syndrome · persistent fetal circulation syndrome · placenta praevia · placental abruption · poisoning · post-cardiac arrest syndrome · post-traumatic stress disorder · sinusitis · status asthmaticus · subacute delirium · subarachnoid hemorrhage · thrombotic thrombocytopenic purpura · urinary system disorder · urinary tract obstruction · uterine disorder · acquired aneurysmal subarachnoid hemorrhage · aorta coarctation · bone disorder · epicondylitis · hand, foot and mouth disease · hemorrhagic disease · intracranial vasospasm · mental disorder · obstetric disorder · peripheral ischemia · pharyngitis · preterm premature rupture of the membranes · temporomandibular joint disorder
Investigated by
Assiut University · Cairo University · Seoul National University Bundang Hospital · Mansoura University · Ain Shams University · Sohag University
+219 more · Mahidol University · National Cancer Institute (NCI) · Seoul National University Hospital · Alexandria University · National Cancer Institute, Egypt · The Hospital for Sick Children · University Hospital, Clermont-Ferrand · University of British Columbia · University of Monastir · University of Sao Paulo General Hospital · Wake Forest University Health Sciences · Yonsei University · Ajou University School of Medicine · Al-Azhar University · Alberta Children's Hospital · Alliance for Clinical Trials in Oncology · Aristotle University Of Thessaloniki · Bonsucesso Federal Hospital · Canadian Institutes of Health Research (CIHR) · Children's Hospital Medical Center, Cincinnati · Children's Hospital of Eastern Ontario · Chongqing Medical University · Christoph Czarnetzki · Complejo Hospitalario Dr. Arnulfo Arias Madrid · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Fayoum University · Hamad Medical Corporation · Indonesia University · Kasr El Aini Hospital · King Edward Medical University · Medical University of Warsaw · NYU Langone Health · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · National Institute of Neurological Disorders and Stroke (NINDS) · Nishtar Medical University · Queen's University · St. Justine's Hospital · Stollery Children's Hospital · Tanta University · The Second People's Hospital of Huai'an · Thomas Jefferson University · University of Sao Paulo · University of Southern California · Wayne State University · Zagazig University · 900th Hospital of PLA Joint Logistic Support Force · Adebayo Joshua Adeniyi · Affiliated Yueqing Hospital of Wenzhou Medical University · Aga Khan University · AnestesiaR · Ankara City Hospital Bilkent · Armed Forces Institute of Urology, Rawalpindi · Arsil Radiansyah · Assistance Publique - Hôpitaux de Paris · Astra USA · Autonomous University of Nuevo León · Avadim Technologies, Inc. · Baylor College of Medicine · Beni-Suef University · Beth Israel Medical Center · Bill and Melinda Gates Foundation · Brazilian National Cancer Institute · Brigham and Women's Hospital · CAMC Health System · Campus-Bio-Medico University · Case Western Reserve University · Centre Hospitalier Universitaire Dijon · Centre Hospitalier du Centre du Valais · Chang Gung Memorial Hospital · Changhai Hospital · Chinese University of Hong Kong · Corewell Health East · Cukurova University · Dana-Farber Cancer Institute · all 225 on the full record

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) TIS-U-SOL IN PLASTIC CONTAINER — 1981-10-06 fda.gov ↗

Trials 249 · started per year

today
US approved 1981
1
1
2
1
1
1
1
1
2
2
2
2
1
3
6
13
10
6
7
11
11
10
15
12
13
16
18
12
24
22
18
1
19811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027202820292030
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 04 trials
Phase 0 NCT06137040 Nov 2023 → May 2025 overdue acute asthma, childhood onset asthma University of Oklahoma Recruiting No outcome recorded
Phase 0 NCT05976464 Jul 2023 → Jul 2025 — Assiut University Completed No outcome recorded
Phase 0 NCT04412850 Dec 2020 → Jun 2021 ischemic stroke Dow University of Health Sciences Unknown No outcome recorded
Phase 0 NCT04256057 Mar → Apr 2020 — Beni-Suef University Unknown No outcome recorded
Phase 113 trials · 1 missed
Phase 1 NCT07126795 Dec 2027 → Dec 2030 expected — Hennepin Healthcare Research Institute Not yet recruiting No outcome recorded
Phase 1 NCT06956521 Jul 2026 → Jul 2027 expected ischemic stroke Baylor College of Medicine Recruiting No outcome recorded
Phase 1 NCT07677917 Jan → Jul 2026 overdue — Ain Shams University Enrolling by invitation No outcome recorded
Phase 1 NCT06455514 Mar 2025 → Mar 2026 overdue cardiac arrest, post-cardiac arrest syndrome NYU Langone Health Recruiting No outcome recorded
Phase 1 NCT06516861 Jan → Feb 2024 — Arsil Radiansyah Completed No outcome recorded
Phase 1 NCT05880693 Jan 2022 → Apr 2023 hypotensive disorder mohamed Completed No outcome recorded
Phase 1 NCT04929626 Jan → Nov 2022 status asthmaticus Ziauddin University Completed No outcome recorded
Phase 1 NCT04481672 Jul → Dec 2021 mesothelioma Dana-Farber Cancer Institute Completed No outcome recorded
Phase 1 NCT04941040 Jul → Oct 2021 supratentorial cancer Kasr El Aini Hospital Completed No outcome recorded
Phase 1 NCT05032781 Jun 2021 → Sep 2024 ischemic stroke Northwell Health Withdrawn No outcome recorded Stop: Enrollment
Phase 1/27 trials
Phase 1/2 NCT06920576 Mar → Jul 2025 overdue chronic rhinosinusitis The Second People's Hospital of Huai'an Active not recruiting No outcome recorded
Phase 1/2 NCT05442931 May → Oct 2022 — Minia University Unknown No outcome recorded
Phase 1/2 NCT04898114 Jun 2021 → Apr 2025 overdue pulmonary hypertension, neonatal Sohag University Recruiting No outcome recorded
Phase 1/2 NCT04328636 Nov 2017 → Jul 2020 persistent fetal circulation syndrome, pulmonary hypertension, neonatal Sohag University Completed No outcome recorded
Phase 1/2 NCT02296931 Mar → Oct 2015 preeclampsia William Marsh Rice University Completed No outcome recorded
Phase 1/2 NCT01502761 Mar 2012 → May 2016 stroke disorder University of Southern California Terminated No outcome recorded Stop: Enrollment
Phase 1/2 NCT00500864 Aug 2004 → Nov 2007 chronic obstructive pulmonary disease University of Sao Paulo Completed No outcome recorded
Phase 218 trials · 3 missed
Phase 2 NCT07836712 Nov 2026 → Nov 2027 expected hepatocellular carcinoma, metastatic melanoma University of Southern California Not yet recruiting No outcome recorded
Phase 2 NCT06975813 Jun → Dec 2025 overdue myofascial pain syndrome Fayoum University Not yet recruiting No outcome recorded
Phase 2 NCT07418671 May → Nov 2025 — Ain Shams University Completed No outcome recorded
Phase 2 NCT05730816 Apr 2023 → Apr 2027 expected mesothelioma Brigham and Women's Hospital Recruiting No outcome recorded
Phase 2 NCT07081581 Aug 2022 → Feb 2023 breast cancer Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey Completed No outcome recorded
Phase 2 NCT04812028 Mar 2021 → Aug 2023 — University of Minnesota Completed No outcome recorded
Phase 2 NCT04638881 Dec 2020 → Apr 2023 dyskinesia of esophagus Stanford University Completed No outcome recorded
Phase 2 NCT04275661 Aug 2020 → Mar 2022 breast cancer Assiut University Completed No outcome recorded
Phase 2 NCT04705142 May 2019 → Dec 2020 perinatal asphyxia Services Institute of Medical Sciences, Pakistan Completed No outcome recorded
Phase 2 NCT03548493 Apr → Aug 2018 — Kasr El Aini Hospital Completed No outcome recorded
Phase 2/310 trials · 1 missed
Phase 2/3 NCT07655817 Jul → Dec 2026 expected delirium, magnesium deficiency Tanta University Recruiting No outcome recorded
Phase 2/3 NCT06676475 Dec 2024 → Feb 2025 overdue myofascial pain syndrome Misr University for Science and Technology Not yet recruiting No outcome recorded
Phase 2/3 NCT05674565 Jan 2023 → Jun 2024 cerebral palsy Zagazig University Unknown No outcome recorded
Phase 2/3 NCT06168773 Nov 2022 → Oct 2023 delirium Ain Shams University Completed No outcome recorded
Phase 2/3 NCT04429893 Jan → Sep 2022 breast cancer, chronic pain syndrome Alexandria University Unknown No outcome recorded
Phase 2/3 NCT04740294 Jul 2021 → Nov 2025 bronchiolitis University of Louisville Withdrawn No outcome recorded Stop: Enrollment
Phase 2/3 NCT02307201 Dec 2014 → Dec 2015 severe pre-eclampsia Complejo Hospitalario Dr. Arnulfo Arias Madrid Completed Mixed
Phase 2/3 NCT02317146 Nov 2013 → Dec 2016 severe pre-eclampsia Complejo Hospitalario Dr. Arnulfo Arias Madrid Completed No outcome recorded
Phase 2/3 NCT01197417 Dec 2010 → Mar 2014 sickle cell disease Medical College of Wisconsin Completed Missed primary
Phase 2/3 NCT02499393 Apr 2010 → Apr 2013 brain hypoxia - ischemia Polish Mother Memorial Hospital Research Institute Completed No outcome recorded
Phase 336 trials · 1 met primary · 8 missed
Phase 3 NCT07632157 Oct 2026 → Dec 2028 expected atrial flutter Wake Forest University Health Sciences Not yet recruiting No outcome recorded
Phase 3 NCT07524972 May 2026 → Apr 2028 expected cerebral palsy Cairo University Recruiting No outcome recorded
Phase 3 NCT06785272 Oct 2025 → Oct 2027 expected asthma Suzanne Schuh Recruiting No outcome recorded
Phase 3 NCT05049707 Nov 2024 → Oct 2025 brain neoplasm Thomas Jefferson University Unknown No outcome recorded
Phase 3 NCT06376916 Oct 2024 → Dec 2026 expected atrial fibrillation, atrial flutter Wake Forest University Health Sciences Recruiting No outcome recorded
Phase 3 NCT06306040 Apr → Nov 2024 delirium Assiut University Unknown No outcome recorded
Phase 3 NCT06026527 Mar → Sep 2024 — Tribhuvan University Teaching Hospital, Institute Of Medicine. Completed No outcome recorded
Phase 3 NCT06626620 Jan → Sep 2024 acute asthma Muhammad Aamir Latif Completed No outcome recorded
Phase 3 NCT05021263 May 2022 → Dec 2023 colorectal cancer Thomas Jefferson University Completed No outcome recorded
Phase 3 NCT05287191 Jan 2022 → Oct 2025 atrial fibrillation Sunnybrook Health Sciences Centre Unknown No outcome recorded
Phase 472 trials · 2 met primary · 1 missed
Phase 4 NCT07840183 Sep 2026 → Sep 2027 expected — Northwestern University Recruiting No outcome recorded
Phase 4 NCT07328893 Dec 2025 → Oct 2026 expected — Tata Main Hospital Recruiting No outcome recorded
Phase 4 NCT07173855 Nov 2025 → Mar 2027 expected — Scarborough General Hospital Recruiting No outcome recorded
Phase 4 NCT06745388 Jul 2025 → Sep 2026 overdue uterine disorder Corewell Health East Recruiting No outcome recorded
Phase 4 NCT06975072 Jul 2025 → Apr 2026 overdue — University of California, San Francisco Recruiting No outcome recorded
Phase 4 NCT06997575 May → Nov 2025 eclampsia Nishtar Medical University Completed No outcome recorded
Phase 4 NCT06442995 Jan 2025 → Jul 2027 expected urinary tract obstruction Reims University Hospital Recruiting No outcome recorded
Phase 4 NCT06720337 Jan 2025 → Jan 2026 overdue — Assiut University Not yet recruiting No outcome recorded
Phase 4 NCT06752525 Jan 2025 → Jan 2026 overdue sinusitis Assiut University Not yet recruiting No outcome recorded
Phase 4 NCT06743919 Jan 2025 → Jan 2026 — Assiut University Completed No outcome recorded
Phase not applicable88 trials · 1 met primary · 4 missed
— NCT07795970 Nov 2026 → Nov 2027 expected acute asthma Thammasat University Not yet recruiting No outcome recorded
— NCT07835529 Nov 2026 → Jul 2027 expected — Sargodha Medical College Not yet recruiting No outcome recorded
— NCT07789600 Sep 2026 → Dec 2027 expected — King Hussein Cancer Center Not yet recruiting No outcome recorded
— NCT07798115 Sep 2026 → Dec 2027 expected — Assiut University Not yet recruiting No outcome recorded
— NCT07793955 Aug → Sep 2026 overdue — Lady Reading Hospital, Pakistan Not yet recruiting No outcome recorded
— NCT07716956 Jul 2026 → Apr 2027 expected infectious disease with sepsis Alexandria University Recruiting No outcome recorded
— NCT07675616 May → Dec 2026 expected lacrimal duct obstruction Cairo University Recruiting No outcome recorded
— NCT07816848 Mar → Jun 2026 — Hasanuddin University Completed No outcome recorded
— NCT07381036 Feb → Jul 2026 overdue — Sohag University Not yet recruiting No outcome recorded
— NCT07377903 Feb → Jul 2026 overdue — Sohag University Not yet recruiting No outcome recorded
Phase not stated1 trial
— NCT01918514 — — State University of New York - Upstate Medical University No longer available No outcome recorded
Comparator or background therapy202 trials
Phase 0 NCT07252505 Comparator Nov 2025 → Oct 2027 expected — Assiut University Not yet recruiting No outcome recorded
Phase 0 NCT06621004 Comparator Aug → Dec 2024 overdue — Ain Shams University Enrolling by invitation No outcome recorded
Phase 0 NCT05880459 Comparator Aug 2023 → Nov 2024 — Assiut University Unknown No outcome recorded
Phase 0 NCT04724655 Background Jan → Jun 2021 poisoning Tanta University Completed No outcome recorded
Phase 0 NCT04498351 Comparator Jun 2020 → Sep 2021 — Cairo University Completed No outcome recorded
Show all 202 trials opens the full record — a long page

News releases announcing trial results or a regulatory action · 2

DateIssuerRelease
2026-05-29 Lupin Limited Regulatory Lupin Receives Approval from U.S. FDA for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets lupin.com ↗
2024-07-16 Lupin Limited Regulatory Lupin Receives Tentative Approval from U.S. FDA for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets lupin.com ↗
Mumbai, Naples, July 16, 2024: Global pharma major Lupin Limited (Lupin) today announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets, 1.479 g/0.225 g/0.188 g, to market a generic equivalent of Sutab® Tablets, 1.479 g/0.225 g/0.188 g, of Braintree Laboratories Inc.

Evidence & citations 20 cited values

Every value below carries the sentence it was read from. 470 sources stand behind the page.

FieldValueCited text
Known as magnesium sulfate “Ketamine and magnesium group (group KM): will receive a bolus of 0.5 mg/kg ketamine added to 50mg/kg magnesium sulfate diluted in 100 ml normal saline over 30 minutes after...” NCT04111848 ↗
343

“One of these adjuvants is magnesium sulfate which is used in combination with local anaesthetics to help reduce onset of effect, prolong the duration of action and to increase...” NCT07451327 ↗

“This is a phase I trial that aims to demonstrate safety and feasibility of administering cold saline, minocycline, and magnesium sulfate intra-arterially immediately after...” NCT05032781 ↗

“In experimental models, magnesium sulfate increases cleavage of newly released vWF by ADAMTS13, decreases the endothelial secretion of ultralarge vWF and inhibits the...” NCT03237819 ↗

“This study will compare intravenous magnesium sulfate with intravenous lidocaine for reducing the cardiovascular response to endotracheal intubation in adult patients...” NCT07793955 ↗

“Trans-foraminal Lumbar Epidural Injection of Dexmedetomidine Against Magnesium Sulfate When Combined With Dexamethasone in Uni-lateral Lower Limb Radicular Pain. Multi-centeric...” NCT05271721 ↗

“Therefore we decided to compare the effect of intravenous injection of magnesium sulfate and lidocaine on the prevention of laryngospasm occurrence, and analgesic requirement...” NCT06761547 ↗

“Half of the patients (selected randomly using random number table) will receive 150mg of magnesium sulfate in the block and the other half will receive 300 mcg of buprenorphine...” NCT05091138 ↗

“A separate mixture of glucose 25% (A.N.B Laboratories, Thailand) 50 mL, potassium chloride (Nida pharma, Thailand) 20 mEq and magnesium sulfate (Atlantic, Thailand) 2 gm was infused” NCT01225159 ↗

“Magnesium sulfate (MgSo4) blocks N-methyl-d-aspartate receptors, and that is why, it was used as an adjuvant to the local anesthetic (LA) in different anesthetic approaches.” NCT05158647 ↗

“There are many tocolytic agents may have a role in conservative management of placenta previa such as magnesium sulfate, calcium channel blockers and β-sympathormimetics.” NCT03542552 ↗

Show 333 more sources

Known as Eziclen “Natrium/ Kalium/ Magnesium sulfate ( Eziclen™, oral solution) 1 L in the evening before colonoscopy” NCT03698474 ↗
Known as IVMg “Children managed for asthma in an emergency department (ED) may be less likely to be hospitalized if they receive intravenous magnesium sulfate (IVMg).” PMID 37459153 ↗ Jul 2023
Known as Magnesium Sulfate Injection 50% Baxter. Number 5430 “Magnesium Sulfate Injection 50% Baxter. Number 5430” NCT02498496 ↗
Known as Magnesium Sulfate Sandoz “Each treatment will utilize 600 mg (1.2 mL) of Magnesium Sulfate Sandoz” NCT01429415 ↗
Known as Magnesium Sulfate, Heptahydrate “Drug: Magnesium Sulfate, Heptahydrate” NCT05166811 ↗
Known as magnesium sulphate “Patients received 40 mg/kg of magnesium sulphate infusion in 100cc normal saline, as a bolus dose, in addition to 0.2mg/kg of ketamine as a bolus dose, 15 min before the...” NCT04095455 ↗
120

“Magnesium sulphate is an intracellular cation with various physiologic functions such as enzyme activation, nerve signal conduction, protein synthesis and vasomotor tonicity regulation.” NCT03008850 ↗

“Pre loading fluid with Magnesium sulphate 16 milliequivalent plus potassium chloride 20 milliequivalent in Normal saline 500 ml IV drip in 4 hours before Cisplatin administration” NCT02481518 ↗

“The present study will examine the effect of administering intravenous magnesium sulphate during anesthesia in patients undergoing elective laparoscopic cholecystectomy surgery.” NCT05598307 ↗

“A previously published study suggested that pre-treatment with magnesium sulphate (MgSO(4)) had no impact on the speed of onset of rocuronium-induced neuromuscular block.” PMID 19919585 ↗ Nov 2009

“The patients receive 20 ml plain bupivacaine(0.5%)+200 milligram magnesium sulphate (2 ml of magnesium 10%) in adductor canal block after spinal anesthesia.” NCT04892420 ↗

“Magnesium sulphate, an antagonist of N-methyl-D-aspartate (NMDA) glutamate receptors, has been reported to improve hypo-magnesia and pre-eclampsia.” NCT06306040 ↗

“Magnesium Sulphate will be given as doses of 20-50mg/kg in 2 -3 minutes. In order to standardize the dose in every patient we will be using 3g” NCT07079514 ↗

“whereas magnesium sulphate (MgSo4) group were given loading dose 40 mg/kg over 15 mins then maintenance dose 15 mg/kg/h till end of surgery.” NCT05850832 ↗

“Magnesium sulphate will be administered at a dose of 6g over 20 min intravenously followed by a continuous infusion of 6g / 24h for 3 days.” NCT03237819 ↗

“Magnesium Sulphate as a drug has been in clinical use for decades; its pharmacokinetics, safety profile and mode of action are well known.” NCT05707962 ↗

Show 110 more sources

Known as magnesuim sulfate “epidural transforaminal injection of magnesuim sulfate” NCT05271721 ↗
Known as magnesuim sulphate “Group M: (magnesuim sulphate group)” NCT05577260 ↗
Known as Magnezyum Sulfat %15 “25 mg MgSO4 (Magnezyum Sulfat %15, Biofarma, Istanbul, Turkey)” NCT05427149 ↗
Known as Magphate “Group A: will receive 4g of 20% intravenous (I.V.) MgSO4 (Magphate®) given over 10 minutes, followed by 3g of 50% intramuscular (I.M.) MgSO4 in each buttock statim.” NCT04501289 ↗
Known as Mg sulfate “The aim of this study is to assess the efficacy of Mg sulfate ( 10% ) as an adjuvant to Bupivacain ( 0.25 % ) in an U.S guided QLB for postoperative analgesia and postoperative...” NCT06301789 ↗
2

“Eligible consenting children will receive three experimental treatments of nebulized salbutamol with either 600 mg of Mg sulfate or placebo 20 min apart” PMID 27220675 ↗ May 2016

“. 200 mg Mg sulfate (1ml) plus 4 mg dexamethasone(1ml) plus 40mg lidocaine 2% (2ml)” NCT05271721 ↗

Known as MGS “Magnesium sulfate (MGS) is a non-competitive antagonist of N-methyl, D-aspartate (NMDA) receptors with an analgesic effect” NCT04391855 ↗
Known as MgSO4 “BACKGROUND: Succinylcholine remains the muscle relaxant of choice for rapid sequence induction (RSI) but has many adverse effects. High-dose rocuronium bromide may be an...” PMID 33337797 ↗ Dec 2021
59

“Magnesium sulfate (MgSO4) will be administered intravenously at induction of anesthesia as a 30-minute bolus dose of 50 mg/kg (maximum 2 grams) in the OR, followed by a 15...” NCT04812028 ↗

“After pre-treatment with a clinically relevant dose of magnesium sulphate (MgSO4), an increased speed of onset and a prolongation of the recovery period of the neuromuscular...” NCT01440933 ↗

“Magnesium sulfate (MgSO4) is an N-Methyl D-Aspartate (NMDA) receptor antagonist that has been used for postoperative analgesia and reducing both the duration and intensity of...” NCT05880732 ↗

“Group 3: IA cold saline + Minocycline + Magnesium sulfate 3-6 patients receive IA cold saline + MTD Minocycline + 2g MgSO4; 3-6 patients receive IA cold saline + MTD...” NCT05032781 ↗

“foetal neuroprotection will be administered consisting of MgSO4 in an intravenous loading dose of 4 g (administered slowly over 20-30 min), followed by a 1 g per hour maintenance dose.” NCT07107477 ↗

“Magnesium sulfate (MgSo4) blocks N-methyl-d-aspartate receptors, and that is why, it was used as an adjuvant to the local anesthetic (LA) in different anesthetic approaches.” NCT05158647 ↗

“compare between effect of nebulized and intravenous magnesium sulfate (MgSO₄) for better treatment of persistent pulmonary hypertension of neonates with less side effects.” NCT06603766 ↗

“A previously published study suggested that pre-treatment with magnesium sulphate (MgSO(4)) had no impact on the speed of onset of rocuronium-induced neuromuscular block.” PMID 19919585 ↗ Nov 2009

“In the Mg group, 30 mg/kg of 10% MgSO4 solution was administered intravenously for over 20 minutes as the loading dose, followed by the continuous infusion of 10 mg/kg/hr” PMID 32770840 ↗ Aug 2020

“The del Nido components are: Plasma-Lyte A (1000ml), Mannitol 20% (16.3ml), MgSO4 50% (4ml) , NaHCO3 8.4% (13ml) , KCl 2mEq/mL (13ml), Lidocaine 1% (13ml).” NCT03818126 ↗

Show 49 more sources

Known as MgSO₄ heptahydrate “a 10% intravenous preparation of MgSO₄ heptahydrate with sterile distilled water” NCT06603766 ↗
Known as Natrium/ Kalium/ Magnesium sulfate ClinicalTrials.gov intervention name — accepted as the source's own label NCT03698474 ↗
Known as Sulfate, Magnesium “Drug: Sulfate, Magnesium” NCT02989272 ↗
1

“Drug: Sulfate, Magnesium” NCT03237819 ↗

Action Inhibit “MgSO(4) inhibits excitatory amino acid release, blocks N-methyl-D-aspartate (NMDA) receptors and prevents calcium entry into the cell.” PMID 16759446 ↗ Jun 2006
Modality Other / unclassified “Magnesium sulphate belongs to the class of electrolytes anti-dysrrhythmic drugs.” NCT04501289 ↗
Route Intravenous “loading dose of magnesium sulfate IV for 20 minutes” NCT00004399 ↗